These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Infectious complications in SLE after immunosuppressive therapies. Kang I; Park SH Curr Opin Rheumatol; 2003 Sep; 15(5):528-34. PubMed ID: 12960476 [TBL] [Abstract][Full Text] [Related]
4. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Fanouriakis A; Kostopoulou M; Andersen J; Aringer M; Arnaud L; Bae SC; Boletis J; Bruce IN; Cervera R; Doria A; Dörner T; Furie RA; Gladman DD; Houssiau FA; Inês LS; Jayne D; Kouloumas M; Kovács L; Mok CC; Morand EF; Moroni G; Mosca M; Mucke J; Mukhtyar CB; Nagy G; Navarra S; Parodis I; Pego-Reigosa JM; Petri M; Pons-Estel BA; Schneider M; Smolen JS; Svenungsson E; Tanaka Y; Tektonidou MG; Teng YO; Tincani A; Vital EM; van Vollenhoven RF; Wincup C; Bertsias G; Boumpas DT Ann Rheum Dis; 2024 Jan; 83(1):15-29. PubMed ID: 37827694 [TBL] [Abstract][Full Text] [Related]
6. Dilemma of immunosuppression and infection risk in systemic lupus erythematosus. He J; Li Z Rheumatology (Oxford); 2023 Mar; 62(Suppl 1):i22-i29. PubMed ID: 36987605 [TBL] [Abstract][Full Text] [Related]
12. Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Danza A; Ruiz-Irastorza G Lupus; 2013 Oct; 22(12):1286-94. PubMed ID: 24098001 [TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study. Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984 [TBL] [Abstract][Full Text] [Related]
14. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity. Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998 [TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine in systemic lupus erythematosus (SLE). Ponticelli C; Moroni G Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040 [TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions. Ugarte A; Danza A; Ruiz-Irastorza G Curr Opin Rheumatol; 2018 Sep; 30(5):482-489. PubMed ID: 29870497 [TBL] [Abstract][Full Text] [Related]
18. New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab. Staveri C; Karokis D; Liossis SC Semin Arthritis Rheum; 2017 Jun; 46(6):788-790. PubMed ID: 27793432 [TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus: safe and effective management in primary care. Michalski JP; Kodner C Prim Care; 2010 Dec; 37(4):767-78, vii. PubMed ID: 21050957 [TBL] [Abstract][Full Text] [Related]